Intra-Arterial Verapamil Treatment in Oral Therapy–Refractory Reversible Cerebral Vasoconstriction Syndrome

References

1. 1.↵
   1. Ducros A

   . Reversible cerebral vasoconstriction syndrome. Lancet Neurol 2012;11:906–17 doi:10.1016/S1474-4422(12)70135-7 pmid:22995694

   CrossRefPubMedWeb of Science
2. 2.↵
   1. Ducros A,
   2. Boukobza M,
   3. Porcher R, et al

   . The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome: a prospective series of 67 patients. Brain 2007;130:3091–3101 doi:10.1093/brain/awm256 pmid:18025032

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Nowak DA,
   2. Rodiek SO,
   3. Henneken S, et al

   . Reversible segmental cerebral vasoconstriction (Call-Fleming syndrome): are calcium channel inhibitors a potential treatment option? Cephalalgia 2003;23:218–22 doi:10.1046/j.1468-2982.2003.00507.x pmid:12662190

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Calabrese LH,
   2. Dodick DW,
   3. Schwedt TJ, et al

   . Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 2007;146:34–44 doi:10.7326/0003-4819-146-1-200701020-00007 pmid:17200220

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Chen SP,
   2. Fuh JL,
   3. Chang FC, et al

   . Transcranial color Doppler study for reversible cerebral vasoconstriction syndromes. Ann Neurol 2008;63:751–57 doi:10.1002/ana.21384 pmid:18496847

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Singhal AB,
   2. Topcuoglu MA,
   3. Fok JW, et al

   . Reversible cerebral vasoconstriction syndromes and primary angiitis of the central nervous system: clinical, imaging, and angiographic comparison. Ann Neurol 2016;79:882–94 doi:10.1002/ana.24652 pmid:27043703

   CrossRefPubMed
7. 7.↵
   1. Singhal AB,
   2. Hajj-Ali RA,
   3. Topcuoglu MA, et al

   . Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol 2011;68:1005–12 doi:10.1001/archneurol.2011.68 pmid:21482916

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Elstner M,
   2. Linn J,
   3. Muller-Schunk S, et al

   . Reversible cerebral vasoconstriction syndrome: a complicated clinical course treated with intra-arterial application of nimodipine. Cephalalgia 2009;29:677–82 doi:10.1111/j.1468-2982.2008.01768.x pmid:19239677

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Al-Mufti F,
   2. Dodson V,
   3. Wajswol E, et al

   . Chemical angioplasty for medically refractory reversible cerebral vasoconstriction syndrome. Br J Neurosurg 2018;32:431–35 doi:10.1080/02688697.2018.1479512 pmid:29607683

   CrossRefPubMed
10. 10.↵
    1. Jun P,
    2. Ko NU,
    3. English JD, et al

    . Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 2010;31:1911–16 doi:10.3174/ajnr.A2183 pmid:20616179

    Abstract/FREE Full Text
11. 11.↵
    1. Keuskamp J,
    2. Murali R,
    3. Chao KH

    . High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 2008;108:458–63 doi:10.3171/JNS/2008/108/3/0458 pmid:18312091

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Sehy JV,
    2. Holloway WE,
    3. Lin SP, et al

    . Improvement in angiographic cerebral vasospasm after intra-arterial verapamil administration. AJNR Am J Neuroradiol 2010;31:1923–28 doi:10.3174/ajnr.A2215 pmid:20705701

    Abstract/FREE Full Text
13. 13.↵
    1. Ansari SA,
    2. Rath TJ,
    3. Gandhi D

    . Reversible cerebral vasoconstriction syndromes presenting with subarachnoid hemorrhage: a case series. J NeuroInterv Surg 2011;3:272–78 doi:10.1136/jnis.2010.004242 pmid:21990840

    Abstract/FREE Full Text
14. 14.↵
    1. Ducros A,
    2. Fiedler U,
    3. Porcher R, et al

    . Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke 2010;41:2505–11 doi:10.1161/STROKEAHA.109.572313 pmid:20884871

    Abstract/FREE Full Text
15. 15.↵
    1. Sattar A,
    2. Manousakis G,
    3. Jensen MB

    . Systematic review of reversible cerebral vasoconstriction syndrome. Expert Rev Cardiovasc Ther 2010;8:1417–21 doi:10.1586/erc.10.124 pmid:20936928

    CrossRefPubMed
16. 16.↵
    1. Noda K,
    2. Fukae J,
    3. Fujishima K, et al

    . Reversible cerebral vasoconstriction syndrome presenting as subarachnoid hemorrhage, reversible posterior leukoencephalopathy, and cerebral infarction. Intern Med 2011;50:1227–33 doi:10.2169/internalmedicine.50.4812 pmid:21628940

    CrossRefPubMed
17. 17.↵
    1. Chen SP,
    2. Fuh JL,
    3. Lirng JF, et al

    . Recurrent primary thunderclap headache and benign CNS angiopathy: spectra of the same disorder? Neurology 2006;67:2164–69 doi:10.1212/01.wnl.0000249115.63436.6d pmid:17190937

    Abstract/FREE Full Text
18. 18.↵
    1. Cappelen-Smith C,
    2. Calic Z,
    3. Cordato D

    . Reversible cerebral vasoconstriction syndrome: recognition and treatment. Curr Treat Options Neurol 2017;19:21 doi:10.1007/s11940-017-0460-7 pmid:28456915

    CrossRefPubMed
19. 19.↵
    1. Ducros A,
    2. Wolff V

    . The typical thunderclap headache of reversible cerebral vasoconstriction syndrome and its various triggers. Headache 2016;56:657–63 doi:10.1111/head.12797 pmid:27015869

    CrossRefPubMed
20. 20.↵
    1. Bartynski WS

    . Posterior reversible encephalopathy syndrome, Part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008;29:1043–49 doi:10.3174/ajnr.A0929 pmid:18403560

    Abstract/FREE Full Text
21. 21.↵
    1. Chen SP,
    2. Fuh JL,
    3. Wang SJ, et al

    . Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes. Ann Neurol 2010;67:648–56 doi:10.1002/ana.21951 pmid:20437562

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Bartynski WS,
    2. Boardman JF

    . Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol 2008;29:447–55 doi:10.3174/ajnr.A0839 pmid:18079186

    Abstract/FREE Full Text
23. 23.↵
    1. Chen SP,
    2. Yang AC,
    3. Fuh JL, et al

    . Autonomic dysfunction in reversible cerebral vasoconstriction syndromes. J Headache Pain 2013;14:94 doi:10.1186/1129-2377-14-94 pmid:24274860

    CrossRefPubMed
24. 24.↵
    1. Calabrese LH,
    2. Gragg LA,
    3. Furlan AJ

    . Benign angiopathy: a distinct subset of angiographically defined primary angiitis of the central nervous system. J Rheumatol 1993;20:2046–50 pmid:8014931

    PubMed
25. 25.↵
    1. Kadkhodayan Y,
    2. Alreshaid A,
    3. Moran CJ, et al

    . Primary angiitis of the central nervous system at conventional angiography. Radiology 2004;233:878–82 doi:10.1148/radiol.2333031621 pmid:15498898

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Chen SP,
    2. Fuh JL,
    3. Wang SJ

    . Reversible cerebral vasoconstriction syndrome: current and future perspectives. Expert Rev Neurother 2011;11:1265–76 doi:10.1586/ern.11.112 pmid:21864073

    CrossRefPubMedWeb of Science
27. 27.↵
    1. French KF,
    2. Hoesch RE,
    3. Allred J, et al

    . Repetitive use of intra-arterial verapamil in the treatment of reversible cerebral vasoconstriction syndrome. J Clin Neurosci 2012;19:174–76 doi:10.1016/j.jocn.2011.06.016 pmid:22118796

    CrossRefPubMed
28. 28.↵
    1. Katz BS,
    2. Fugate JE,
    3. Ameriso SF, et al

    . Clinical worsening in reversible cerebral vasoconstriction syndrome. JAMA Neurol 2014;71:68–73 doi:10.1001/jamaneurol.2013.4639 pmid:24190097

    CrossRefPubMed
29. 29.↵
    1. Singhal AB,
    2. Topcuoglu MA

    . Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome. Neurology 2017;88:228–36 doi:10.1212/WNL.0000000000003510 pmid:27940651

    Abstract/FREE Full Text
30. 30.↵
    1. Rascher W,
    2. Dietz R,
    3. Schomig A, et al

    . Modulation of sympathetic vascular tone by prostaglandins in corticosterone-induced hypertension in rats. Clin Sci 1979;57(Suppl 5):235s–37s. doi:10.1042/cs057235s pmid:540439

    Abstract/FREE Full Text
31. 31.↵
    1. Leroux G,
    2. Sellam J,
    3. Costedoat-Chalumeau N, et al

    . Posterior reversible encephalopathy syndrome during systemic lupus erythematosus: four new cases and review of the literature. Lupus 2008;17:139–47 doi:10.1177/0961203307085405 pmid:18250139

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Kumai Y,
    2. Seguchi O,
    3. Sato T, et al

    . Reversible cerebral vasoconstriction syndrome after heart transplantation: a case report. Transplant Proc 2017;49:2415–18 doi:10.1016/j.transproceed.2017.10.016 pmid:29198694

    CrossRefPubMed
33. 33.↵
    1. Farid H,
    2. Tatum JK,
    3. Wong C, et al

    . Reversible cerebral vasoconstriction syndrome: treatment with combined intra-arterial verapamil infusion and intracranial angioplasty. AJNR Am J Neuroradiol 2011;32:E184–87 doi:10.3174/ajnr.A2341 pmid:21273351

    Abstract/FREE Full Text
34. 34.↵
    1. Laneuville M,
    2. Ding J,
    3. Shamy M, et al

    . Intra-arterial milrinone may differentiate fulminant RCVS from vasculitis. Neurology 2017;89:1093–94 doi:10.1212/WNL.0000000000004337 pmid:28871063

    Abstract/FREE Full Text
35. 35.↵
    1. Linn J,
    2. Fesl G,
    3. Ottomeyer C, et al

    . Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a diagnostic tool in select cases? Cephalalgia 2011;31:1074–81 doi:10.1177/0333102410394673 pmid:21220377

    CrossRefPubMedWeb of Science
36. 36.↵
    1. Bouchard M,
    2. Verreault S,
    3. Gariepy JL, et al

    . Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome. Headache 2009;49:142–45 doi:10.1111/j.1526-4610.2008.01211.x pmid:18647181

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Albanese E,
    2. Russo A,
    3. Quiroga M, et al

    . Ultrahigh-dose intraarterial infusion of verapamil through an indwelling microcatheter for medically refractory severe vasospasm: initial experience. Clinical article. J Neurosurg 2010;113:913–22 doi:10.3171/2009.9.JNS0997 pmid:19877802

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Jabbarli R,
    2. Pierscianek D,
    3. Rolz R, et al

    . Endovascular treatment of cerebral vasospasm after subarachnoid hemorrhage: more is more. Neurology 2019;93:e458–66 doi:10.1212/WNL.0000000000007862 pmid:31278116

    Abstract/FREE Full Text